Orion - Company Announcement

The Board of Directors of Orion Corporation decided on an incentive plan for key persons

ORION CORPORATION  STOCK EXCHANGE RELEASE    2 FEB 2016  AT 14:45 PM
EET


The Board of Directors of Orion Corporation decided on an incentive plan for key
persons

The Board of Directors of Orion Corporation has decided on a new share-based
incentive plan for the Group key persons. The aim of the Plan is to combine the
objectives of the shareholders and the key persons in order to increase the
value of the Company, to commit the key persons to the Company, and to offer
them a competitive reward plan based on holding the Company's shares.

The Plan includes earning periods. The Board of Directors decides annually on
the beginning and duration of the earning periods in 2016, 2017 and 2018. The
Board of Directors decides on the earnings criteria and on targets to be
established for them at the beginning of each earning period. Two earning
periods, calendar year 2016 and calendar years 2016-2018,commenced upon
implementation of the Plan. The potential reward of the Plan, for the earning
period 2016, is based on the Orion Group's operating profit and, for the earning
period 2016-2018, on the total return on Orion Corporation class B share.

The potential reward will be paid partly as the Company's class B shares and
partly in cash in 2017, on the basis of the earning period 2016, and in 2019 on
the basis of the earning period 2016-2018. The proportion to be paid in cash
will be used for taxes and tax-related costs arising from the reward to a key
person. The value of reward to be paid on the basis of the Plan and the Orion
Share-based incentive plan established in 2013 during one calendar year is a key
person's gross annual salary multiplied by 1.75, in the maximum, at the date of
the reward payment. Gross annual salary means total salary together with fringe
benefits, excluding annual bonus and long-term incentive plan. The shares paid
on the basis of the earning period 2016 cannot be transferred during the
restriction period, which will end on 31 December 2018 with the exception that
notwithstanding the transfer restrictions relating to the shares to be paid on
the basis of the Plan, a person belonging to the Plan may purchase Orion
Corporation A shares at will and at his/her expense on the stock exchange or
otherwise and enter these shares under the transfer restriction of the Plan, and
after the acquisition transfer a corresponding number of B shares under the
transfer restriction.

The target group of the Plan consists of 50 people, in the maximum. The total
maximum amount of rewards to be paid on the basis of the Plan is 500,000 Orion
Corporation class B shares and a cash payment corresponding to the value of the
shares.


Orion Corporation



Timo Lappalainen             Olli Huotari
President and CEO           SVP, Corporate Functions

Contact person:
Olli Huotari, SVP, Corporate Functions, tel. +358 10 426 3054, mobile
+358 50 966 3054



Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo
Homepage: www.orion.fi

Orion is a globally operating Finnish company developing pharmaceuticals and
diagnostic tests - a builder of well-being. Orion develops, manufactures and
markets human and veterinary pharmaceuticals, active pharmaceutical ingredients
and diagnostic tests. The company is continuously developing new drugs and
treatment methods. The core therapy areas of Orion's pharmaceutical R&D are
central nervous system (CNS) disorders, oncology and respiratory for which Orion
develops inhaled Easyhaler(®) pulmonary drugs.

Orion's net sales in 2015 amounted to EUR 1,016 million and the Company had
about 3,400 employees. Orion's A and B shares are listed on Nasdaq Helsinki.


[HUG#1983037]